延迟根治性前列腺切除术与不良肿瘤学结局无关:对COVID-19疫情期间手术延迟的启示
本研究基于美国国家癌症数据库回顾性分析2010至2016年间接受根治性前列腺切除术的128,062例中高危前列腺癌患者,比较立即手术(诊断后3个月内)与延迟手术(以3个月为间隔至12个月)的肿瘤学结局。多因素逻辑回归显示,延迟手术与不良病理、升级、淋巴结阳性或术后二次治疗均无显著关联;Grade Group 4和5亚组亦无关联。结论提示延迟根治性前列腺切除术未增加早期不良肿瘤学结局。
要点
- 延迟根治性前列腺切除术至12个月未增加不良病理、升级、淋巴结阳性或术后二次治疗风险。
- Grade Group 4和5高危患者亚组中,延迟手术亦未显示更差肿瘤学结局。
- 结果可为疫情期间平衡手术时机提供 reassurance,但需结合个体情况决策。
核心结论
- 在美国国家癌症数据库中,延迟根治性前列腺切除术与术后早期不良肿瘤学结局无关。
研究设计与样本
- 回顾性队列研究,纳入美国国家癌症数据库2010至2016年接受根治性前列腺切除术的中高危前列腺癌男性128,062例。
- 立即手术定义为诊断后3个月内手术,延迟手术按3个月间隔分析至12个月。
主要发现
- 多因素逻辑回归调整后,立即手术与任何延迟水平(至12个月)在不良病理、升级、淋巴结阳性或术后二次治疗几率上无显著差异。
- Grade Group 4和5前列腺癌亚组分析未显示延迟手术与更差肿瘤学结局相关。
关键数值与推荐
- 延迟手术分析间隔为3个月,最长至12个月。
- 结局包括不良病理、根治性前列腺切除术中的升级、淋巴结阳性疾病和术后二次治疗。
临床怎么用
- 为因COVID-19疫情等导致手术延迟的患者和泌尿外科医生提供平衡决策的参考依据。
- 中高危前列腺癌患者短期延迟(至12个月)可能不显著影响早期肿瘤学结局,但仍需个体化评估。
局限性
- 回顾性研究设计,可能存在选择偏倚和未测量混杂因素。
- 仅评估早期肿瘤学结局,缺乏长期随访数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The 2019 novel Coronavirus (COVID-19) pandemic has forced many health care organizations to divert efforts and resources to emergent patient care, delaying many elective oncologic surgeries. We investigated an association between delay in radical prostatectomy and oncologic outcomes. MATERIALS AND METHODS: This is a retrospective review of men with intermediate and high risk prostate cancer in the National Cancer Database undergoing radical prostatectomy from 2010 to 2016. Immediate radical prostatectomy was defined as radical prostatectomy within 3 months of diagnosis, while delayed radical prostatectomy was analyzed in 3-month intervals up to 12 months. Multivariable logistic regression models were fit to test for associations between levels of delayed radical prostatectomy and outcomes of interest (adverse pathology, upgrading on radical prostatectomy, node positive disease and post-radical prostatectomy secondary treatments) compared with men undergoing immediate radical prostatectomy. RESULTS: We identified 128,062 men with intermediate and high risk prostate cancer treated with radical prostatectomy. After adjustment, we did not appreciate a significant difference in odds of adverse pathology, upgrading, node positive disease or post-radical prostatectomy secondary treatments between men treated with immediate radical prostatectomy and any level of delay up to 12 months. Subgroup analysis of men with Grade Group 4 and 5 prostate cancer did not demonstrate an association between delayed radical prostatectomy and worse oncologic outcomes. CONCLUSIONS: In the National Cancer Database delayed radical prostatectomy was not associated with early adverse oncologic outcomes at radical prostatectomy. These results may provide reassurance to patients and urologists balancing care in the current pandemic.
引用
- Ginsburg KB, Curtis GL, Timar RE, et al. Delayed Radical Prostatectomy is Not Associated with Adverse Oncologic Outcomes: Implications for Men Experiencing Surgical Delay Due to the COVID-19 Pandemic. J Urol. 2020. PMID: 32356508. doi:10.1097/JU.0000000000001089
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。